Advanced search
Publication Cover
Future Oncology Volume 7, 2011 - Issue 10
Submit an article Journal homepage
386
Views
0
CrossRef citations to date
0
Altmetric
Research Article

The Prognostic Value of Histological Tumor Necrosis in Solid Organ Malignant Disease: A Systematic Review

Colin H Richards1 Glasgow University Department of Surgery, Glasgow, UK. [email protected]Correspondence[email protected]
View further author information
,
Zahra Mohammed1 Glasgow University Department of Surgery, Glasgow, UK. [email protected]View further author information
,
Tahir Qayyum1 Glasgow University Department of Surgery, Glasgow, UK. [email protected]View further author information
,
Paul G Horgan1 Glasgow University Department of Surgery, Glasgow, UK. [email protected]View further author information
&
Donald C McMillan1 Glasgow University Department of Surgery, Glasgow, UK. [email protected]View further author information
Pages 1223-1235 | Published online: 12 Oct 2011

Bibliography

  • Gohagan JK , ProrokPC, HayesRB, KramerBS. The prostate, lung, colorectal and ovarian (PLCO) cancer screening trial of the National Cancer Institute: history, organization and status.Control Clin. Trials21, 251S–272S (2000).
  • Vakkila J , LotzeMT. Inflammation and necrosis promote tumor growth.Nat. Rev. Immunol.4, 641–648 (2004).
  • Hanahan D , WeinbergRA. Hallmarks of cancer: the next generation.Cell144, 646–674 (2011).
  • Proctor MJ , TalwarD, BalmarSMet al. The relationship between the presence and site of cancer, an inflammation-based prognostic score and biochemical parameters. Initial results of the Glasgow Inflammation Outcome Study. Br. J. Cancer 103, 870–876 (2010).
  • Galon J , CostesA, Sanchez-CaboFet al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science 313, 1960–1964 (2006).
  • Klintrup K , MakinenJM, KauppilaSet al. Inflammation and prognosis in colorectal cancer. Eur. J. Cancer 41, 2645–2654 (2005).
  • Roxburgh CS , SalmondJM, HorganPG, OienKA, McMillanDC. Tumor inflammatory infiltrate predicts survival following curative resection for node-negative colorectal cancer.Eur. J. Cancer45, 2138–2145 (2009).
  • Frank I , BluteML, ChevilleJC, LohseCM, WeaverAL, ZinckeH. An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score.J. Urol.168, 2395–2400 (2002).
  • Fisher ER , PalekarAS, GregorioRM, RedmondC, FisherB. Pathological findings from the national surgical adjuvant breast project (Protocol No. 4). IV. Significance of tumor necrosis.Hum. Pathol.9, 523–530 (1978).
  • Swinson DE , JonesJL, RichardsonD, CoxG, EdwardsJG, O’ByrneKJ. Tumor necrosis is an independent prognostic marker in non-small cell lung cancer: correlation with biological variables.Lung Cancer37, 235–240 (2002).
  • Pollheimer MJ , KornpratP, LindtnerRAet al. Tumor necrosis is a new promising prognostic factor in colorectal cancer. Hum. Pathol. 41, 1749–1757 (2010).
  • Gabay C , KushnerI. Acute-phase proteins and other systemic responses to inflammation.N. Engl J. Med.340, 448–454 (1999).
  • Sengupta S , LohseCM, LeibovichBCet al. Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness. Cancer 104, 511–520 (2005).
  • Edwards JG , SwinsonDE, JonesJL, MullerS, WallerDA, O’ByrneKJ. Tumor necrosis correlates with angiogenesis and is a predictor of poor prognosis in malignant mesothelioma.Chest124, 1916–1923 (2003).
  • Klatte T , SaidJW, de MartinoMet al. Presence of tumor necrosis is not a significant predictor of survival in clear cell renal cell carcinoma: higher prognostic accuracy of extent based rather than presence/absence classification. J. Urol. 181, 1558–1564 (2009).
  • Amtrup F , HansenJB, ThyboE. Prognosis in renal carcinoma evaluated from histological criteria.Scand J. Urol. Nephrol8, 198–202 (1974).
  • Roosen JU , EngelU, JensenRH, KvistE, SchouG. Renal cell carcinoma: prognostic factors.Br J. Urol.74, 160–164 (1994).
  • Sabo E , BoltenkoA, SovaY, SteinA, KleinhausS, ResnickMB. Microscopic analysis and significance of vascular architectural complexity in renal cell carcinoma.Clin. Cancer Res.7, 533–537 (2001).
  • Moch H , GasserT, AminMB, TorhorstJ, SauterG, MihatschMJ. Prognostic utility of the recently recommended histologic classification and revised TNM staging system of renal cell carcinoma: a Swiss experience with 588 tumors.Cancer89, 604–614 (2000).
  • Amin MB , AminMB, TamboliPet al. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am. J. Surg. Pathol. 26, 281–291 (2002).
  • Cheville JC , LohseCM, ZinckeH, WeaverAL, BluteML. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma.Am. J. Surg. Pathol.27, 612–624 (2003).
  • Lam JS , ShvartsO, SaidJWet al. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma. Cancer 103, 2517–2525 (2005).
  • Ficarra V , MartignoniG, MaffeiNet al. Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma. Cancer 103, 68–75 (2005).
  • Lee SE , ByunSS, OhJKet al. Significance of macroscopic tumor necrosis as a prognostic indicator for renal cell carcinoma. J. Urol. 176, 1332–1337 (2006).
  • Zubac DP , BostadL, GestblomCet al. Renal cell carcinoma: a clinicopathological follow-up study after radical nephrectomy. Scand. J. Urol. Nephrol. 41, 191–197 (2007).
  • Brinker DA , AminMB, de Peralta-VenturinaM, ReuterV, ChanDY, EpsteinJI. Extensively necrotic cystic renal cell carcinoma: a clinicopathologic study with comparison to other cystic and necrotic renal cancers.Am. J. Surg. Pathol.24, 988–995 (2000).
  • Leibovich BC , BluteML, ChevilleJCet al. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer 97, 1663–1671 (2003).
  • Frank I , BluteML, ChevilleJCet al. A multifactorial postoperative surveillance model for patients with surgically treated clear cell renal cell carcinoma. J. Urol. 170, 2225–2232 (2003).
  • Amin MB , CorlessCL, RenshawAA, TickooSK, KubusJ, SchultzDS. Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases.Am. J. Surg. Pathol.21, 621–635 (1997).
  • Delahunt B , NaceyJN. Renal cell carcinoma. II. Histological indicators of prognosis.Pathology19, 258–263 (1987).
  • Leibovitch I , LevR, MorY, GolombJ, DotanZA, RamonJ. Extensive necrosis in renal cell carcinoma specimens: potential clinical and prognostic implications.Isr. Med. Assoc. J.3, 563–565 (2001).
  • Sorbellini M , KattanMW, SnyderMEet al. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. J. Urol. 173, 48–51 (2005).
  • Lee SE , HongSK, HanBKet al. Prognostic significance of tumor necrosis in primary transitional cell carcinoma of upper urinary tract. Jpn J. Clin. Oncol. 37, 49–55 (2007).
  • Seitz C , GuptaA, ShariatSFet al. Association of tumor necrosis with pathological features and clinical outcome in 754 patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma: an international validation study. J. Urol. 184, 1895–1900 (2010).
  • Langner C , HuttererG, ChromeckiT, LeiblS, RehakP, ZigeunerR. Tumor necrosis as prognostic indicator in transitional cell carcinoma of the upper urinary tract.J. Urol.176, 910–913 (2006).
  • Carter D , PipkinRD, ShepardRH, ElkinsRC, AbbeyH. Relationship of necrosis and tumor border to lymph node metastases and 10-year survival in carcinoma of the breast.Am. J. Surg. Pathol.2, 39–46 (1978).
  • Carlomagno C , PerroneF, LauriaRet al. Prognostic significance of necrosis, elastosis, fibrosis and inflammatory cell reaction in operable breast cancer. Oncology 52, 272–277 (1995).
  • Kato T , KimuraT, MiyakawaRet al. Clinicopathologic study associated with long-term survival in Japanese patients with node-negative breast cancer. Br. J. Cancer. 82, 404–411 (2000).
  • Ikpatt O , Ndoma-EgbaR, CollanY. Prognostic value of necrosis in Nigerian breast cancer.Adv. Clin. Path.6, 31–37 (2002).
  • Gilchrist KW , GrayR, FowbleB, TormeyDC, TaylorSG. Tumor necrosis is a prognostic predictor for early recurrence and death in lymph node-positive breast cancer: a 10-year follow-up study of 728 Eastern Cooperative Oncology Group patients.J. Clin. Oncol.11, 1929–1935 (1993).
  • Marques LA , FrancoEL, TorloniH, BrentaniMM, da Silva-NetoJB, BrentaniRR. Independent prognostic value of laminin receptor expression in breast cancer survival.Cancer Res.50, 1479–1483 (1990).
  • Shek LL , GodolphinW. Model for breast cancer survival: relative prognostic roles of axillary nodal status, TNM stage, estrogen receptor concentration, and tumor necrosis.Cancer Res.48, 5565–1569 (1988).
  • Fisher ER , LandSR, SaadRSet al. Pathologic variables predictive of breast events in patients with ductal carcinoma in situ. Am. J. Clin. Pathol. 128, 86–91 (2007).
  • Rilke F , ColnaghiMI, CascinelliNet al. Prognostic significance of HER-2/neu expression in breast cancer and its relationship to other prognostic factors. Int. J. Cancer 49, 44–49 (1991).
  • Kato T , KimuraT, MiyakawaRet al. Clinicopathologic study of angiogenesis in Japanese patients with breast cancer. World J. Surg. 21, 49–56 (1997).
  • Leek RD , LandersRJ, HarrisAL, LewisCE. Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast.Br. J. Cancer79, 991–995 (1999).
  • Lee AH , GillettCE, RyderK, FentimanIS, MilesDW, MillisRR. Different patterns of inflammation and prognosis in invasive carcinoma of the breast.Histopathology48, 692–701 (2006).
  • Eerola AK , RuokolainenH, SoiniY, RaunioH, PääkköP. Accelerated apoptosis and low bcl-2 expression associated with neuroendocrine differentiation predict shortened survival in operated large cell carcinoma of the lung.Pathol. Oncol. Res.5, 179–186 (1999).
  • Kessler R , GasserB, MassardGet al. Blood vessel invasion is a major prognostic factor in resected non-small cell lung cancer. Ann. Thorac. Surg. 62, 1489–1493 (1996).
  • Shahab I , FraireAE, GreenbergSD, JohnsonEH, LangstonC, RoggliVL. Morphometric quantitation of tumor necrosis in stage 1 non-small cell carcinoma of lung: prognostic implications.Mod. Pathol.5, 521–524 (1992).
  • Lipford EH 3rd , EgglestonJC, LillemoeKD, SearsDL, MooreGW, BakerRR. Prognostic factors in surgically resected limited-stage, nonsmall cell carcinoma of the lung.Am. J. Surg. Pathol.8, 357–365 (1984).
  • Demirag F , UnsalE, YilmazA, CaglarA. Prognostic significance of vascular endothelial growth factor, tumor necrosis, and mitotic activity index in malignant pleural mesothelioma.Chest128, 3382–3387 (2005).
  • Gao JF , ArbmanG, WadhraTI, ZhangH, SunXF. Relationships of tumor inflammatory infiltration and necrosis with microsatellite instability in colorectal cancers.World J. Gastroenterol.11, 2179–2183 (2005).
  • Svennevig JL , LundeOC, HolterJ, Bj⊘rgsvikD. Lymphoid infiltration and prognosis in colorectal carcinoma.Br. J. Cancer49, 375–377 (1984).
  • Mulcahy HE , TonerM, PatchettSE, DalyL, O’DonoghueDP. Identifying stage B colorectal cancer patients at high risk of tumor recurrence and death.Dis. Colon Rectum40, 326–331 (1997).
  • Knutsen A , AdellG, SunXF. Inflammatory infiltration, fibrosis, necrosis and mucinous content in relation to clinicopathological and molecular factors in rectal cancers with or without preoperative radiotherapy.Oncol. Rep.16, 321–327 (2006).
  • Gustafson P . Soft tissue sarcoma. Epidemiology and prognosis in 508 patients.Acta Orthop. Scand. (Suppl.)259, 1–31 (1994).
  • Gustafson P , AkermanM, AlvegårdTAet al. Prognostic information in soft tissue sarcoma using tumor size, vascular invasion and microscopic tumor necrosis-the SIN-system. Eur. J. Cancer 39, 1568–1576 (2003).
  • Carneiro A , BendahlPO, EngellauJet al. A prognostic model for soft tissue sarcoma of the extremities and trunk wall based on size, vascular invasion, necrosis, and growth pattern. Cancer 117, 1279–1287 (2011).
  • Llombart-Bosch A , ContessoG, Henry-AmarMet al. Histopathological predictive factors in Ewing’s sarcoma of bone and clinicopathological correlations. A retrospective study of 261 cases. Virchows Arch. A Pathol. Anat. Histopathol. 409, 627–640 (1986).
  • Hiraoka N , InoY, SekineSet al. Tumor necrosis is a postoperative prognostic marker for pancreatic cancer patients with a high interobserver reproducibility in histological evaluation. Br. J. Cancer 103, 1057–1065 (2010).
  • Volante M , LandolfiS, ChiusaLet al. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients. Cancer 100, 950–957 (2004).
  • Hiltzik D , CarlsonDL, TuttleRMet al. Poorly differentiated thyroid carcinomas defined on the basis of mitosis and necrosis: a clinicopathologic study of 58 patients. Cancer 106, 1286–1295 (2006).
  • Muro-Cacho CA , CantorAB, MorganM. Prognostic factors in malignant gastrointestinal stromal tumors.Ann. Clin. Lab. Sci.30, 239–247 (2000).
  • Soini Y , VirkajärviN, LehtoVP, PääkköP. Hepatocellular carcinomas with a high proliferation index and a low degree of apoptosis and necrosis are associated with a shortened survival.Br. J. Cancer73, 1025–1030 (1996).
  • Iimura Y , SaitoK, FujiiYet al. Development and external validation of a new outcome prediction model for patients with clear cell renal cell carcinoma treated with nephrectomy based on preoperative serum C-reactive protein and TNM classification: the TNM-C score. J. Urol. 181, 1004–1012 (2009).
  • Manola J , RoystonP, ElsonPet al.; International Kidney Cancer Working Group. Prognostic Model for Survival in Patients with Metastatic Renal Cell Carcinoma: results from the International Kidney Cancer Working Group. Clin. Cancer Res.17(16), 5443–5450 (2011) (Epub ahead of print).
  • Liao D , JohnsonRS. Hypoxia: a key regulator of angiogenesis in cancer.Cancer Metastasis Rev.26, 281–290 (2007).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.